Top Abstract Purchase Related
Home
>
Node
>
Subnode

An approach to the medical management of inflammatory bowel disease

Bartnik, W.; Shorter, R.G.

Materia Medica Polona. Polish Journal of Medicine and Pharmacy 13(2): 93-99

1981

ISSN/ISBN: 0025-5246
PMID: 6124660
Document Number: 175505
Following appendectomy and sublethal (450 rads) whole body X-irradiation, reconstitution with autologous appendix germinal centre cells led to excellent germinal centre formation in the recipient's spleen. Heat killing of the cells to be injected completely abolished this phenomenon. Apparently a suspension of appendix germinal centre cells contains a (sub)populations of cells capable of germinal centre formation (Germinal Centre Precursor Cells). Following whole body X-irradiation while shielding the appendix, germinal centre activity could only be detected after antigenic stimulation in otherwise normally regenerated splenic follicular structures. This suggests that the cell population recently derived from appendix germinal centres is able to function once again as a population of germinal centre precursors.

Document emailed within 1 workday
Secure & encrypted payments

Bartnik, W.; Shorter, R.G. 1981: An approach to the medical management of inflammatory bowel disease Przeglad Lekarski 38(6): 499-505
Manser, W.W. 1990: Management of inflammatory bowel disease JPMA. Journal of the Pakistan Medical Association 40(11): 279
Springall, R.G. 1986: Surgical management of nonspecific inflammatory bowel disease British Journal of Hospital Medicine 35(4): 220-226
Befeler, A.S.; Lissoos, T.W.; Schiano, T.D.; Conjeevaram, H.; Dasgupta, K.A.; Millis, J.M.; Newell, K.A.; Thistlethwaite, J.R.; Baker, A.L. 1998: Clinical course and management of inflammatory bowel disease after liver transplantation Transplantation 65(3): 393-396
Pac-Kozuchowska, E.; Krawiec, P.; Mroczkowska-Juchkiewicz, A. 2014: Fecal lactoferrin in identifying and management of inflammatory bowel disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 37(217): 61-64
Guerra, I.án.; Bermejo, F. 2015: Biological drugs in inflammatory bowel disease: Management and care Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 107(7): 454
Cox, J. 1995: Inflammatory bowel disease: implications for the medical-surgical nurse Medsurg Nursing: Official Journal of the Academy of Medical-Surgical Nurses 4(6): 427
Johnson, W.R.; Hughes, E.S.; McDermott, F.T.; Polglase, A.L.; Pihl, E.A. 1982: Inflammatory bowel disease--where are we? A review of ulcerative colitis and Crohn's disease, highlighting the problems of aetiology, epidemiology, clinical factors and management Medical Journal of Australia 1(5): 226-229
Loly, J.-P.; Somja, J.; Reenaers, C.; Van Kemseke, C.; Gast, P.; Louis, E. 2017: Interest of confocal endomicroscopy for the management of chronic inflammatory bowel disease Revue Medicale Suisse 13(571): 1431-1434
Grandbastien, B.; Gower-Rousseau, C.; Merle, V.; Dupas, J.L.; Yzet, T.; Lerebours, E.; Marti, R.; Laine, I.; Cortot, A.; Salomez, J.L. 1999: Diagnostic and therapeutic management of patients with chronic inflammatory bowel disease Revue d'Epidemiologie et de Sante Publique 47(1): 45-53
Hindryckx, P.; Amininejad, L.; Van De Vijver, E.; Bossuyt, P. 2014: Belgian recommendations for the management of anemia in patients with inflammatory bowel disease Acta Gastro-Enterologica Belgica 77(3): 333-344
Banerjee, S.; Peppercorn, M.A. 2002: Inflammatory bowel disease. Medical therapy of specific clinical presentations Gastroenterology Clinics of North America 31(1): 185-202 X
Quah, S.H. 2013: Role of probiotics and nutrition in the management of chronic inflammatory bowel disease in children Singapore Medical Journal 54(4): 183-184
Andrisani, G.; Guidi, L.; Papa, A.; Armuzzi, A. 2012: Anti-TNF alpha therapy in the management of extraintestinal manifestation of inflammatory bowel disease European Review for Medical and Pharmacological Sciences 16(7): 890-901
Ward, B.; Shah, S.; Eaden, J.A.; Mayberry, J.F. 1998: Patients with inflammatory bowel disease: their response to information leaflets about medical therapy in particular azathioprine Arquivos de Gastroenterologia 35(4): 264-266
Weiss, D.J.; Gagne, J.M.; Armstrong, P.J. 1996: Relationship between inflammatory hepatic disease and inflammatory bowel disease, pancreatitis, and nephritis in cats Journal of the American Veterinary Medical Association 209(6): 1114-1116
Silberer, H.; Küppers, B.; Mickisch, O.; Baniewicz, W.; Drescher, M.; Traber, L.; Kempf, A.; Schmidt-Gayk, H. 2005: Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome Clinical Laboratory 51(3-4): 117-126
Walker, E.A.; Katon, W.J.; Roy-Byrne, P.P.; Jemelka, R.P.; Russo, J. 1993: Histories of sexual victimization in patients with irritable bowel syndrome or inflammatory bowel disease American Journal of Psychiatry 150(10): 1502-1506
Brullet, E.; Bonfill, X.; Urrútia, G.; Ruiz Ochoa, V.; Cueto, M.; Clofent, J.; Martínez Salmerón, J.F.; Riera, J.; Obrador, A. 1998: Epidemiological study on the incidence of inflammatory bowel disease in 4 Spanish areas. Spanish Group on the Epidemiological Study of Inflammatory Bowel Disease Medicina Clinica 110(17): 651-656
Veljaca, M. 2001: Anti-inflammatory peptides and proteins in inflammatory bowel disease Current Opinion in Investigational Drugs 2(10): 1387-1394